{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:59:58Z","timestamp":1744221598630,"version":"3.37.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013129","name":"Against Breast Cancer","doi-asserted-by":"publisher","award":["1121258"],"award-info":[{"award-number":["1121258"]}],"id":[{"id":"10.13039\/100013129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bbadis.2023.166837","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T02:05:44Z","timestamp":1691201144000},"page":"166837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Could anionic LDL be a ligand for RAGE and TREM2 in addition to LOX-1 and thus exacerbate lung disease and dementia?"],"prefix":"10.1016","volume":"1869","author":[{"given":"Charles N.","family":"Birts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbadis.2023.166837_bb0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tibs.2009.08.003","article-title":"Catalytic and non-catalytic functions of human IIA phospholipase A2","volume":"35","author":"Birts","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166837_bb0010","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1074\/jbc.M708844200","article-title":"A catalytically independent physiological function for human acute phase protein group IIA phospholipase A2: cellular uptake facilitates cell debris removal","volume":"283","author":"Birts","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166837_bb0015","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1074\/jbc.M109777200","article-title":"The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall","volume":"277","author":"Beers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166837_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2021.110646","article-title":"Age, obesity and hyperglycaemia: activation of innate immunity initiates a series of molecular interactions involving anionic surfaces leading to COVID-19 morbidity and mortality","volume":"155","author":"Birts","year":"2021","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166837_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","article-title":"Targeting RAGE signaling in inflammatory disease","volume":"69","author":"Hudson","year":"2018","journal-title":"Annu. Rev. Med."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166837_bb0030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tibs.2011.08.008","article-title":"RAGE: a single receptor fits multiple ligands","volume":"36","author":"Fritz","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166837_bb0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10719-016-9694-y","article-title":"Pathways of the Maillard reaction under physiological conditions","volume":"33","author":"Henning","year":"2016","journal-title":"Glycoconj. J."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166837_bb0040","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1016\/j.bbadis.2018.08.036","article-title":"Mechanistic targeting of advanced glycation end-products in age-related diseases","volume":"1864","author":"Rowan","year":"2018","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"12","key":"10.1016\/j.bbadis.2023.166837_bb0045","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.bbadis.2023.166837_bb0050","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.4049\/jimmunol.1700373","article-title":"A consensus definitive classification of scavenger receptors and their roles in health and disease","volume":"198","author":"PrabhuDas","year":"2017","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166837_bb0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/dom.14638","article-title":"Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin","volume":"24","author":"Gomez-Peralta","year":"2022","journal-title":"Diabetes. Obes. Metab."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166837_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/glycob\/cwi053","article-title":"Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation","volume":"15","author":"Ramasamy","year":"2005","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166837_bb0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ncpendmet0786","article-title":"Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications","volume":"4","author":"Yan","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166837_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10719-021-09980-0","article-title":"Dicarbonyl stress, protein glycation and the unfolded protein response","volume":"38","author":"Rabbani","year":"2021","journal-title":"Glycoconj. J."},{"issue":"50","key":"10.1016\/j.bbadis.2023.166837_bb0075","doi-asserted-by":"crossref","first-page":"12673","DOI":"10.1021\/bi00165a018","article-title":"Amadori rearrangement potential of hemoglobin at its glycation sites is dependent on the three-dimensional structure of protein","volume":"31","author":"Nacharaju","year":"1992","journal-title":"Biochemistry"},{"issue":"49","key":"10.1016\/j.bbadis.2023.166837_bb0080","doi-asserted-by":"crossref","first-page":"16077","DOI":"10.1002\/anie.201810037","article-title":"A systematic study of selective protein glycation","volume":"57","author":"Sjoblom","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166837_bb0085","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1038\/s41467-021-23625-8","article-title":"Synergistic sequence contributions bias glycation outcomes","volume":"12","author":"McEwen","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166837_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/biomedicines8120550","article-title":"Molecular and cellular mechanisms of electronegative lipoproteins in cardiovascular diseases","volume":"8","author":"Ke","year":"2020","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.bbadis.2023.166837_bb0095","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2174\/0929867325666180330093953","article-title":"Electronegative LDL: an active player in Atherogenesis or a by- product of atherosclerosis?","volume":"26","author":"Rivas-Urbina","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"18","key":"10.1016\/j.bbadis.2023.166837_bb0100","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/eurheartj\/ehaa770","article-title":"Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease","volume":"42","author":"Akhmedov","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166837_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/ATVBAHA.120.315421","article-title":"Role of LOX-1 (lectin-like oxidized low-density lipoprotein receptor 1) as a cardiovascular risk predictor","volume":"41","author":"Barreto","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166837_bb0110","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/jcm10091992","article-title":"Autoimmune rheumatic diseases: An update on the role of Atherogenic electronegative LDL and potential therapeutic strategies","volume":"10","author":"Chen","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166837_bb0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1073\/pnas.76.1.333","article-title":"Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition","volume":"76","author":"Goldstein Joseph","year":"1979","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.bbadis.2023.166837_bb0120","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1073\/pnas.78.10.6499","article-title":"Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins","volume":"78","author":"Henriksen","year":"1981","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166837_bb0125","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.3390\/ijms24065747","article-title":"The oxidized lipoproteins in vivo: its diversity and behavior in the human circulation","volume":"24","author":"Itabe","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166837_bb0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/00365519309088399","article-title":"Glycation and oxidation of human low density lipoproteins reduces heparin binding and modifies charge","volume":"53","author":"Creriche","year":"1993","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166837_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1194\/jlr.M000422","article-title":"Mechanism of LDL binding and release probed by structure-based mutagenesis of the LDL receptor [S]","volume":"51","author":"Huang","year":"2010","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166837_bb0140","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2174\/0929867325666180508100950","article-title":"Role of ox-LDL and LOX-1 in Atherogenesis","volume":"26","author":"Kattoor","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166837_bb0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/antiox8070218","article-title":"LOX-1: regulation, signaling and its role in atherosclerosis","volume":"8","author":"Kattoor","year":"2019","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166837_bb0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/nyas.13984","article-title":"Targeting LOX-1 in atherosclerosis and vasculopathy: current knowledge and future perspectives","volume":"1443","author":"Tian","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6620","key":"10.1016\/j.bbadis.2023.166837_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/386073a0","article-title":"An endothelial receptor for oxidized low-density lipoprotein","volume":"386","author":"Sawamura","year":"1997","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166837_bb0160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MOL.0b013e32835688e4","article-title":"LOX-1: a multiligand receptor at the crossroads of response to danger signals","volume":"23","author":"Sawamura","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166837_bb0165","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.str.2005.03.016","article-title":"Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL","volume":"13","author":"Ohki","year":"2005","journal-title":"Structure"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166837_bb0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10557-011-6322-8","article-title":"LOX-1 transcription","volume":"25","author":"Hermonat","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166837_bb0175","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jmb.2017.04.004","article-title":"TREM2-ligand interactions in health and disease","volume":"429","author":"Kober","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166837_bb0180","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166837_bb0185","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bbadis.2023.166837_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167470","article-title":"Variant TREM2 signaling in Alzheimer\u2019s disease","volume":"434","author":"Olufunmilayo","year":"2022","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166837_bb0195","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.3390\/ijms22126609","article-title":"Understanding the role of protein glycation in the amyloid aggregation process","volume":"22","author":"Sirangelo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.bbadis.2023.166837_bb0200","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105380","article-title":"Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia","volume":"39","author":"Scott-Hewitt","year":"2020","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166837_bb0205","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 is a receptor for \u03b2-amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"issue":"43","key":"10.1016\/j.bbadis.2023.166837_bb0210","doi-asserted-by":"crossref","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2) *","volume":"290","author":"Atagi","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"43","key":"10.1016\/j.bbadis.2023.166837_bb0215","doi-asserted-by":"crossref","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","article-title":"The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E","volume":"290","author":"Bailey","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bbadis.2023.166837_bb0220","doi-asserted-by":"crossref","first-page":"12057","DOI":"10.1074\/jbc.M115.702399","article-title":"Regulation of receptor for advanced glycation end products (RAGE) Ectodomain shedding and its role in cell function*","volume":"291","author":"Braley","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166837_bb0225","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2008.04.002","article-title":"Interleukin 18 stimulates release of soluble lectin-like oxidized LDL receptor-1 (sLOX-1)","volume":"202","author":"Mitsuoka","year":"2009","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.bbadis.2023.166837_bb0230","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.15252\/emmm.201707673","article-title":"TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant","volume":"9","author":"Thornton","year":"2017","journal-title":"EMBO Molecular Medicine"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166837_bb0235","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cvr\/cvp036","article-title":"RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice","volume":"82","author":"Sun","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166837_bb0240","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41593-021-00801-z","article-title":"Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia","volume":"24","author":"Dong","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166837_bb0245","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.nbd.2008.12.001","article-title":"Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer\u2019s disease","volume":"33","author":"Kankaanp\u00e4\u00e4","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166837_bb0250","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1096\/fj.12-222216","article-title":"Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1","volume":"27","author":"Schreurs","year":"2013","journal-title":"FASEB J."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392300203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392300203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T17:24:54Z","timestamp":1733073894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392300203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S092544392300203X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166837","relation":{},"ISSN":["0925-4439"],"issn-type":[{"type":"print","value":"0925-4439"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could anionic LDL be a ligand for RAGE and TREM2 in addition to LOX-1 and thus exacerbate lung disease and dementia?","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166837"}}